Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer.
Nakane T, Fukunaga S, Nakano D, Tsutsumi T, Tanaka H, Chou T, Minami S, Ohuchi A, Nagata T, Takaki K, Takaki H, Miyajima I, Nouno R, Yoshinaga S, Mukasa M, Okabe Y, Kawaguchi T.
Nakane T, et al. Among authors: fukunaga s.
Hepatol Res. 2024 Jun;54(6):540-550. doi: 10.1111/hepr.14010. Epub 2024 Jan 20.
Hepatol Res. 2024.
PMID: 38156966